Tenet Healthcare Continues To Win In Q2, But Medicaid Cuts May Threaten Growth Beyond 2026

  • Tenet Healthcare remains a buy, consistently beating earnings and raising guidance, even as the healthcare sector faces broad pressure from looming Medicaid cuts. Ambulatory segment growth is key, as it is higher margin and less exposed to Medicaid risk than the hospital segment, which faces headwinds post-2026. Medicaid cuts are now law and will hit hardest after 2026, posing significant long-term risk to hospital revenues despite Tenet's restructuring efforts.